Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person13
ClearPoint Neuro, Inc.
Company
CLEARONE INC
Company
NexPoint Capital, Inc.
Company
Neurogene Inc.
Company
NeuroPace Inc
Company
Clearfield, Inc.
Company
Alzamend Neuro, Inc.
Company
Neuronetics, Inc.
Company
Cleartronic, Inc.
Company
Clear Secure, Inc.
Company
EyePoint, Inc.
Company
Neuraxis, INC
Company
AvePoint, Inc.
Company
Primary record6
ClearPoint Neuro, Inc. filed 8-K
Item 2.02 Results of Operations and Financial Condition. On October 28, 2026, ClearPoint Neuro, Inc. (the “Company”) issued a press release announcing its financial results for the third fiscal quarter ended September 30
ClearPoint Neuro, Inc. filed 4
SEC form 4 filed by ClearPoint Neuro, Inc. (CIK 1285550) on 2026-10-02.
ClearPoint Neuro, Inc. filed 4
SEC form 4 filed by ClearPoint Neuro, Inc. (CIK 1285550) on 2026-10-02.
ClearPoint Neuro, Inc. filed 4
SEC form 4 filed by ClearPoint Neuro, Inc. (CIK 1285550) on 2026-09-03.
ClearPoint Neuro, Inc. filed SCHEDULE 13G/A
on August 3, 2026. MAK Capital Fund LP a D0 0.00 2375861.00 0.00 2375861.00 2375861.00 7.8 PN The calculation is based upon 2,375,861 shares of Common Stock beneficially owned as of 06/30/2026 and a total of 30,504,227 s
ClearPoint Neuro, Inc. filed 10-Q
SEC form 10-Q filed by ClearPoint Neuro, Inc. (CIK 1285550) on 2026-08-03.